AAB
DGX icon

ABN AMRO Bank’s Quest Diagnostics DGX Stock Holding History

ABN AMRO Bank’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5M Buy
101,667
+7,027
+7% +$1.38M 0.28% 64
2026
Q1 		$18.7M Buy
94,640
+5,658
+6% +$1.1M 0.2% 73
2025
Q4 		$15.4M Sell
88,982
-503
-0.6% -$91.6K 0.14% 81
2025
Q3 		$17M Sell
89,485
-1,713
-2% -$304K 0.17% 73
2025
Q2 		$16.5M Buy
91,198
+5,234
+6% +$909K 0.21% 55
2025
Q1 		$14.5M Buy
85,964
+3,681
+4% +$605K 0.2% 60
2024
Q4 		$12.3M Sell
82,283
-1,390
-2% -$216K 0.17% 61
2024
Q3 		$12.9M Sell
83,673
-5,341
-6% -$798K 0.18% 60
2024
Q2 		$12.3M Buy
89,014
+452
+0.5% +$61.9K 0.19% 59
2024
Q1 		$11.8M Buy
88,562
+757
+0.9% +$98.2K 0.18% 58
2023
Q4 		$12.2M Sell
87,805
-570
-0.6% -$74.9K 0.2% 58
2023
Q3 		$10.8M Buy
88,375
+67,743
+328% +$9.03M 0.19% 57
2023
Q2 		$2.91M Sell
20,632
-1,844
-8% -$254K 0.06% 76
2023
Q1 		$3.18M Buy
+22,476
New +$3.22M 0.07% 73

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

ABN AMRO Bank's DGX Position: Q2 2026 in Review

ABN AMRO Bank increased its Quest Diagnostics (DGX) stake by 7.4% in Q2 2026, buying an estimated $1.38M and bringing the position to 101,667 shares worth $21.5M. The position accounts for 0.28% of the portfolio, ranked #64.

ABN AMRO Bank first reported a position in DGX in Q1 2023 and has held it in 14 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • ABN AMRO Bank held 101,667 shares of Quest Diagnostics worth $21.5M as of Q2 2026.
  • ABN AMRO Bank bought 7,027 Quest Diagnostics shares in Q2 2026, an estimated $1.38M.
  • Quest Diagnostics made up 0.28% of ABN AMRO Bank's portfolio in Q2 2026, its #64 holding.
  • ABN AMRO Bank first reported a position in Quest Diagnostics in Q1 2023 and has held it in 14 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.